How to Take Wegovy Shots for Effective Weight Management

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has demonstrated profound effects on weight reduction when prescribed off-label. Learning proper injection technique, recognizing how your body responds at each dose level, and understanding what to expect during treatment can help you achieve sustainable results. PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies, allowing you to access this medication without insurance at an affordable starting price of $149 per month.

Understanding Semaglutide Injection Basics

Semaglutide works by mimicking GLP-1, a hormone that regulates blood sugar and appetite. When you inject semaglutide subcutaneously once weekly, it activates receptors in your brain that signal fullness, slow stomach emptying, and reduce hunger hormones. This triple mechanism makes the medication exceptionally effective for weight management in adults with obesity or overweight status. The injectable form reaches peak concentration within 1-3 days and maintains steady levels throughout the week, supporting consistent appetite suppression.

Clinical trials show that patients using semaglutide lose significantly more weight than those using lifestyle changes alone. A landmark study published in the New England Journal of Medicine found that participants receiving semaglutide achieved mean weight loss of 15.3 kg (33.7 lbs) compared to 2.6 kg in the placebo group over 68 weeks. Your individual response depends on genetics, metabolic rate, concurrent medications, and adherence to dosing schedules. PlexusDx can help determine if genetic variants in your GLP1R gene (rs6923761) or other peptide pathways might influence your treatment response.

Proper Injection Technique and Administration Steps

Semaglutide injections are administered subcutaneously—meaning under the skin—once per week on the same day each week. Recommended injection sites include your abdomen, thigh, or upper arm; rotating injection sites prevents lipodystrophy (tissue damage from repeated injections). Before each injection, allow the pen or vial to reach room temperature for at least 15 minutes, then visually inspect the medication for particles or discoloration. If you see cloudiness or crystals, discard the medication and use a fresh vial. Pinch the skin gently, insert the needle at a 90-degree angle, and hold steady while the injection completes—typically 5–10 seconds depending on your device.

After injecting, withdraw the needle and apply gentle pressure with a sterile gauze pad if needed. Store your semaglutide in the refrigerator between 2°C and 8°C (36°F and 46°F) before first use; after opening, most preparations remain stable at room temperature (up to 30°C/86°F) for 28 days. Keep a detailed log of injection dates, sites, and any side effects you experience. This information helps your PlexusDx clinician adjust your protocol if needed and ensures you receive consistent, effective therapy. Never share your medication pen or vial with others, even if they have similar weight management needs.

Dose Escalation and What to Expect at Each Level

Semaglutide dosing typically begins low to minimize gastrointestinal side effects and allows your body to adapt gradually. Most protocols start at 0.25 mg once weekly for 4 weeks, then increase by 0.25 mg increments every 4 weeks until reaching a maintenance dose of 1.0 to 2.4 mg weekly. Some patients experience maximal benefit at lower doses, while others require higher doses for optimal appetite suppression and weight loss. Your dose may need to go up—your price won't. PlexusDx charges a flat monthly fee regardless of which dose you're using, removing financial barriers to finding your ideal therapeutic level.

During weeks 1–4 at your starting dose, expect mild nausea, reduced appetite, and possible loose stools as your gastrointestinal tract adjusts. These effects typically resolve within 3–5 days of each dose increase. By week 8–12, most patients report stable appetite suppression and begin noticing weight loss. Energy levels often improve as you consume fewer calories and lose weight. If you experience persistent vomiting, severe abdominal pain, or rapid heartbeat, contact your healthcare provider immediately. PlexusDx clinicians monitor your progress and side effect profile throughout your treatment journey to ensure safe, effective care.

Integrating Semaglutide with Lifestyle and Genetic Insights

Semaglutide is most effective when combined with structured lifestyle changes—moderate exercise, whole-food nutrition, and consistent sleep. The medication removes the hunger barrier, making it far easier to maintain a caloric deficit without constant willpower. Research shows that patients combining semaglutide with behavioral counseling lose 20–25% more body weight than those using medication alone. PlexusDx supports this integrated approach by connecting you with guidance on nutrition, movement, and stress management alongside your injection protocol.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide myself, or do I need a healthcare provider to administer it?

Semaglutide is designed for self-administration using a pre-filled pen or vial with an insulin syringe. You'll receive clear instructions and may watch a demonstration video before your first injection. Most patients feel comfortable self-injecting after one or two guided attempts. PlexusDx provides detailed written and video guidance to ensure your technique is safe and effective.

How quickly will I see weight loss results from semaglutide injections?

Most patients begin noticing appetite reduction within 3–5 days of their first injection. Measurable weight loss typically appears after 4–6 weeks as reduced calorie intake compounds. Clinical trials show average weight loss of 1–2 pounds per week, though individual results vary based on starting weight, genetics, diet quality, and activity level. PlexusDx clinicians help you establish realistic timelines and celebrate milestone achievements throughout your journey.

What is PlexusDx's pricing model for semaglutide injections, and are there hidden dose-based costs?

PlexusDx charges a flat $189 per month for compounded semaglutide injections across all tiers—your dose may increase, but your price won't. There are no insurance requirements, membership fees, or per-dose surcharges. All medications come from licensed 503A compounding pharmacies and are HSA/FSA eligible, making precision weight management genuinely affordable.

What are the most common side effects, and how long do they last?

Nausea, reduced appetite, constipation, and fatigue are the most frequent side effects, typically appearing after dose increases and resolving within 3–5 days. Serious side effects—including rapid heartbeat, severe abdominal pain, persistent vomiting, or signs of pancreatitis—require immediate medical attention. Most patients tolerate semaglutide well, and side effects diminish over time as your body adapts. PlexusDx monitors your experience closely and adjusts your protocol if needed.

How does the Precision Peptide Genetic Test help optimize my semaglutide therapy?

PlexusDx's Precision Peptide Genetic Test analyzes variants in your GIPR, FTO, and MC4R genes to reveal how your body's appetite regulation and peptide-signaling pathways function. If you carry a GLP1R rs6923761 variant associated with heightened GLP-1 receptor sensitivity, you may achieve excellent results at lower doses. Conversely, certain FTO genetic patterns suggest higher dose requirements. This $298 test—available after your first treatment month—enables truly personalized dosing that maximizes results and minimizes side effects.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Providers That Take Fsa Plexusdx
• Wegovy Weight Loss Pills

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.